MARKET

TIL

TIL

Instil Bio, Inc.
NASDAQ
13.21
-0.03
-0.19%
Opening 11:55 05/12 EDT
OPEN
13.49
PREV CLOSE
13.23
HIGH
14.01
LOW
13.00
VOLUME
30.31K
TURNOVER
--
52 WEEK HIGH
92.00
52 WEEK LOW
9.62
MARKET CAP
86.61M
P/E (TTM)
-1.1596
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIL last week (0505-0509)?
Weekly Report · 6h ago
Weekly Report: what happened at TIL last week (0428-0502)?
Weekly Report · 05/05 09:43
Weekly Report: what happened at TIL last week (0421-0425)?
Weekly Report · 04/28 09:46
Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus
Seeking Alpha · 04/27 18:10
Merck gains after latest survival data for Summit’s cancer drug
Seeking Alpha · 04/25 19:25
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 04/25 17:06
Weekly Report: what happened at TIL last week (0414-0418)?
Weekly Report · 04/21 09:46
Here's Why Summit Therapeutics Stock Soared 15% on Friday
NASDAQ · 04/14 09:57
More
About TIL
More
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. The Company’s subsidiary, Axion Bio, Inc., in-licensed certain bispecific antibodies, including AXN-2510/IMM2510 and AXN-27M/IMM27M, a monoclonal antibody targeting cytotoxic T-lymphocyte associated antigen 4, or CTLA-4. AXN-2510/IMM2510, the lead in-licensed product candidate, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers. AXN-27M/IMM27M is an antibody-dependent cellular cytotoxicity-enhanced monoclonal antibody targeting CTLA-4, which has been designed to promote intratumoral regulatory T cell depletion to enhance the efficacy and reduce the toxicity associated with first-generation anti-CTLA-4 antibodies.
Recently
Symbol
Price
%Change

Webull offers Instil Bio Inc stock information, including NASDAQ: TIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIL stock methods without spending real money on the virtual paper trading platform.